Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers

We began analyzing https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.40323, but it redirected us to https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.40323. The analysis below is for the second page.

Title[redir]:
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis - Weinblatt - 2018 - Arthritis & Rheumatology - Wiley Online Library
Description:
Objective This 24-week, phase IIb, double-blind study was undertaken to evaluate the efficacy and safety of mavrilimumab (a monoclonal antibody to granulocyte–macrophage colony-stimulating factor re...

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Insurance

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

The income method remains a mystery to us.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

patients, mavrilimumab, week, study, treatment, golimumab, response, group, acr, antitnfir, population, weeks, dmardir, dascrp, percentage, improvement, score, dosage, efficacy, data, baseline, safety, antitnf, disease, rates, inadequate, history, compared, crp, higher, randomized, received, clinical, agents, groups, haq, receiving, stratum, observed, pulmonary, drug, difference, phase, activity, rate, figure, results, reported, tnf, based,

Topics {✒️}

granulocyte–macrophage colony-stimulating factor article information search anti–tumor necrosis factor long-term ole study anti-tnf–ir stratum compared disease-modifying antirheumatic drugs anti-tnf–ir ra population c-reactive protein level anti-tnf–ir stratum prior anti-tnf failures full access previous anti-tnf failures anti-tnf–ir group anti-tnf–ir population anti-tnf–ir strata prior anti-tnf treatment anti–gm-csf autoantibodies privacy policy skip treatment-emergent adverse events dmard-ir stratum recruited open-label extension c-reactive protein health assessment questionnaire anti-tnf agents 2 anti-tnf agents 2 anti-tnf failures treatment visit rheumatoid arthritis michael anti-tnf–ir article content skip biologic agent–experienced patients anti-tnf stratum received research funding anti-tnf failure anti-tnf agent cell costimulation [abatacept] tnf antagonist failures rheumatoid factor–positive gm-csf signaling gm-csf receptor astrazeneca/medimmune study group interleukin-6 receptor [tocilizumab] nonsteroidal antiinflammatory drugs acr70 response rates reducing cell numbers clinical trials good clinical practice antidrug antibody response higher response rates higher disease activity

External Links {🔗}(223)

Analytics and Tracking {📊}

  • Facebook Pixel
  • Site Verification - Google

Libraries {📚}

  • Dropzone.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
3.83s.